Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

816 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, Münzel T, Cambien F, Tiret L, Blankenberg S; AtheroGene Investigators. Schnabel R, et al. Among authors: blankenberg s. Eur Heart J. 2005 Feb;26(3):241-9. doi: 10.1093/eurheartj/ehi036. Epub 2004 Nov 30. Eur Heart J. 2005. PMID: 15618051
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Jachmann N, Post F, Peetz D, Bickel C, Cambien F, Tiret L, Münzel T. Schnabel R, et al. Among authors: blankenberg s. Circ Res. 2005 Sep 2;97(5):e53-9. doi: 10.1161/01.RES.0000181286.44222.61. Epub 2005 Aug 11. Circ Res. 2005. PMID: 16100045
B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, Cambien F, Tiret L, Münzel T, Blankenberg S. Schnabel R, et al. Among authors: blankenberg s. J Am Coll Cardiol. 2006 Feb 7;47(3):552-8. doi: 10.1016/j.jacc.2005.09.039. Epub 2006 Jan 18. J Am Coll Cardiol. 2006. PMID: 16458135 Free article.
Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
Sinning JM, Bickel C, Messow CM, Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Lackner KJ, Tiret L, Münzel T, Blankenberg S; AtheroGene Investigators. Sinning JM, et al. Among authors: blankenberg s. Eur Heart J. 2006 Dec;27(24):2962-8. doi: 10.1093/eurheartj/ehl362. Epub 2006 Nov 28. Eur Heart J. 2006. PMID: 17132649
Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
Keller T, Messow CM, Lubos E, Nicaud V, Wild PS, Rupprecht HJ, Bickel C, Tzikas S, Peetz D, Lackner KJ, Tiret L, Münzel TF, Blankenberg S, Schnabel RB. Keller T, et al. Among authors: blankenberg s. Eur Heart J. 2009 Feb;30(3):314-20. doi: 10.1093/eurheartj/ehn598. Epub 2009 Jan 19. Eur Heart J. 2009. PMID: 19153178
Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study.
Kempf T, Sinning JM, Quint A, Bickel C, Sinning C, Wild PS, Schnabel R, Lubos E, Rupprecht HJ, Münzel T, Drexler H, Blankenberg S, Wollert KC. Kempf T, et al. Among authors: blankenberg s. Circ Cardiovasc Genet. 2009 Jun;2(3):286-92. doi: 10.1161/CIRCGENETICS.108.824870. Epub 2009 Mar 31. Circ Cardiovasc Genet. 2009. PMID: 20031597
816 results